ロード中...
Repeated courses of escalating doses of Nivolumab in refractory Hodgkin lymphoma with recurrent relapses post allografting: A safe and effective treatment approach
For patients with Hodgkin Lymphoma (HL) who experience relapse post allogeneic stem cell transplantation, limited treatment options exist, and the ultimate outcome is poor. Recently, the programmed cell death protein-1 (PD-1) inhibitors have shown remarkable efficacy in patients with refractory/rela...
保存先:
| 出版年: | Hematol Rep |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
PAGEPress Publications, Pavia, Italy
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7967268/ https://ncbi.nlm.nih.gov/pubmed/33747411 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4081/hr.2021.8780 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|